Skip to Main Content

Paper Details

The Quandary of DNA-Based Treatment Assessment in De Novo Metastatic Prostate Cancer in the Era of Precision Oncology.
J Pers Med
1
2021
Author NameAffiliation
Sigve NakkenInstitute for Cancer Research, Oslo University Hospital-Radium Hospital
Sigve NakkenUniversity of Oslo
Wolfgang LillebyOslo University Hospital-Radium Hospital
Alfonso UrbanucciInstitute for Cancer Research, Oslo University Hospital-Radium Hospital
Eivind HovigInstitute for Cancer Research, Oslo University Hospital-Radium Hospital
Eivind HovigUniversity of Oslo
  • 1 - 6

Datasets

Release 1.2